Testing effectiveness (Phase 2)UnknownNCT06550752What this trial is testingErectile Dysfunction Treatment Using Stem CellsWho this might be right forErectile Dysfunction COR clinic of Regenerative Medicine 30
Early research (Phase 1)Study completedNCT00361049What this trial is testingDonor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantWho this might be right forCancer Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Looking for participantsNCT02693535What this trial is testingTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerWho this might be right forLymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors American Society of Clinical Oncology 4,200
Large-scale testing (Phase 3)Not Yet RecruitingNCT06742138What this trial is testingTo Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple MyelomaWho this might be right forMultiple Myeloma Qilu Pharmaceutical Co., Ltd. 284
Not applicableStudy completedNCT01487031What this trial is testingMusic Therapy on Nausea and Pain for Autologous Stem CellWho this might be right forMultiple MyelomaNon-Hodgkin LymphomaHodgkin Lymphoma Case Comprehensive Cancer Center 108
Not applicableApproved For MarketingNCT05463939What this trial is testingTeclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma PatientsWho this might be right forRelapsed or Refractory Multiple Myeloma Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT00081939What this trial is testingUARK 2003-33, Total Therapy IIIWho this might be right forMultiple Myeloma University of Arkansas 303
Large-scale testing (Phase 3)Active Not RecruitingNCT04934475What this trial is testingMInimal Residual Disease Adapted StrategyWho this might be right forMultiple Myeloma Intergroupe Francophone du Myelome 791
Testing effectiveness (Phase 2)Looking for participantsNCT04661137What this trial is testingSelinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Hackensack Meridian Health 96
Not applicableLooking for participantsNCT07774845What this trial is testingPlatelets and Plasma Lipids Relationship as a Biomarker and Potential Therapeutic Target of ThrombogenesisWho this might be right forCardio Vascular Disease University of Sao Paulo 45
Testing effectiveness (Phase 2)WithdrawnNCT01055301What this trial is testingS0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple MyelomaWho this might be right forMultiple MyelomaPlasma Cell Myeloma SWOG Cancer Research Network
Large-scale testing (Phase 3)Study completedNCT02257957What this trial is testingPlatelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry EyeWho this might be right forDry EyeSjogren Syndrome Universidad Nacional de Colombia 30
Large-scale testing (Phase 3)Study completedNCT01497522What this trial is testingEfficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Novartis Pharmaceuticals 183
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439123What this trial is testingTesting AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 35
Very early researchLooking for participantsNCT07085559What this trial is testingSafety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical ResearchWho this might be right forMultiple Myeloma (MM)Plasma Cell Leukemia (PCL)AL Amyloidosis (AL) Anhui Provincial Hospital 36
Not applicableStudy completedNCT05335824What this trial is testingThe Effect of Autologous Platelet Concentrations on Orthodontic Treatment TimeWho this might be right forClass II Division 1 Malocclusion Damascus University 60
Large-scale testing (Phase 3)Ended earlyNCT00256776What this trial is testingMMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous TransplantationWho this might be right forMultiple Myeloma European Society for Blood and Marrow Transplantation 269
Large-scale testing (Phase 3)Study completedNCT03952091What this trial is testingTJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma in RelapseRefractory Multiple Myeloma TJ Biopharma Co., Ltd. 289
Testing effectiveness (Phase 2)Study completedNCT00006013What this trial is testingSU5416 in Treating Patients With Refractory or Relapsed Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Fox Chase Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT04847050What this trial is testingA Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor TherapyWho this might be right forSolid Tumor MalignancyHematologic MalignancyLeukemia+2 more National Cancer Institute (NCI) 19